<DOC>
	<DOC>NCT02778919</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy, safety, and dose-response relationship of KLH-2109 compared to placebo in Japanese patients with endometriosis.</brief_summary>
	<brief_title>Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Female patients with endometriosis Patients with clinically significant hepatic, renal, or cardiovascular dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Endometriosis</keyword>
</DOC>